PRISM BioLab Co Stock

PRISM BioLab Co Net Income 2025

PRISM BioLab Co Net Income

-1.05 B JPY

Ticker

206A.T

ISIN

JP3833190006

In 2025, PRISM BioLab Co's profit amounted to -1.05 B JPY, a 99.18% increase from the -526.91 M JPY profit recorded in the previous year.

The PRISM BioLab Co Net Income history

YEARNET INCOME (undefined JPY)
2024-1,049.51
2023-526.91
202272.96

PRISM BioLab Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into PRISM BioLab Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by PRISM BioLab Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects PRISM BioLab Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of PRISM BioLab Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into PRISM BioLab Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing PRISM BioLab Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on PRISM BioLab Co’s growth potential.

PRISM BioLab Co Revenue, EBIT and net profit per share

DatePRISM BioLab Co RevenuePRISM BioLab Co EBITPRISM BioLab Co Net Income
2024305.62 M undefined-782.39 M undefined-1.05 B undefined
2023112.93 M undefined-496.87 M undefined-526.91 M undefined
2022554.4 M undefined66.68 M undefined72.96 M undefined

PRISM BioLab Co stock margins

The PRISM BioLab Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PRISM BioLab Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PRISM BioLab Co.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the PRISM BioLab Co's sales revenue. A higher gross margin percentage indicates that the PRISM BioLab Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the PRISM BioLab Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the PRISM BioLab Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the PRISM BioLab Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the PRISM BioLab Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the PRISM BioLab Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

PRISM BioLab Co Margin History

PRISM BioLab Co Gross marginPRISM BioLab Co Profit marginPRISM BioLab Co EBIT marginPRISM BioLab Co Profit margin
202452.53 %-256 %-343.4 %
202371.11 %-439.99 %-466.6 %
202296.53 %12.03 %13.16 %

PRISM BioLab Co Aktienanalyse

What does PRISM BioLab Co do?

PRISM BioLab Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding PRISM BioLab Co's Profit Margins

The profit margins of PRISM BioLab Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of PRISM BioLab Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating PRISM BioLab Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

PRISM BioLab Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When PRISM BioLab Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about PRISM BioLab Co stock

How much profit has PRISM BioLab Co made this year?

PRISM BioLab Co has made -1.05 B JPY this year.

How has the profit developed compared to last year?

The profit has increased by 99.18% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does PRISM BioLab Co publish its earnings?

PRISM BioLab Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of PRISM BioLab Co?

The profits of PRISM BioLab Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of PRISM BioLab Co?

You can learn more about the earnings of PRISM BioLab Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does PRISM BioLab Co pay?

Over the past 12 months, PRISM BioLab Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PRISM BioLab Co is expected to pay a dividend of 0 JPY.

What is the dividend yield of PRISM BioLab Co?

The current dividend yield of PRISM BioLab Co is .

When does PRISM BioLab Co pay dividends?

PRISM BioLab Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PRISM BioLab Co?

PRISM BioLab Co paid dividends every year for the past 0 years.

What is the dividend of PRISM BioLab Co?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is PRISM BioLab Co located?

PRISM BioLab Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von PRISM BioLab Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PRISM BioLab Co from 1/22/2025 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 1/22/2025.

When did PRISM BioLab Co pay the last dividend?

The last dividend was paid out on 1/22/2025.

What was the dividend of PRISM BioLab Co in the year 2024?

In the year 2024, PRISM BioLab Co distributed 0 JPY as dividends.

In which currency does PRISM BioLab Co pay out the dividend?

The dividends of PRISM BioLab Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PRISM BioLab Co

Our stock analysis for PRISM BioLab Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PRISM BioLab Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.